Is SoFi Stock a Buy Under $20?
After briefly flirting with penny‑stock territory during the 2022 bear…
Buy
60
SBIO Quote, Financials, Valuation and Earnings
Last price:
$30.30
Seasonality move
:
0.46%
Day range:
$30.30 - $30.71
52-week range:
$22.33 - $42.73
Dividend yield:
3.87%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.9K
Avg. volume:
14.3K
1-year change:
-8.91%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
|
ACES
ALPS Clean Energy ETF
|
-- | -- | -- | -- | -- |
|
AMLP
Alerian MLP ETF
|
-- | -- | -- | -- | -- |
|
ENFR
ALPS Alerian Energy Infrastructure ETF
|
-- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
RDOG
ALPS REIT Dividend Dogs ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SBIO
ALPS Medical Breakthroughs ETF
|
$30.35 | -- | -- | -- | $1.17 | 3.87% | -- |
|
ACES
ALPS Clean Energy ETF
|
$25.72 | -- | -- | -- | $0.02 | 0.93% | -- |
|
AMLP
Alerian MLP ETF
|
$48.94 | -- | -- | -- | $0.98 | 7.85% | -- |
|
ENFR
ALPS Alerian Energy Infrastructure ETF
|
$32.10 | -- | -- | -- | $0.38 | 4.43% | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$38.90 | -- | -- | -- | $0.03 | 0% | -- |
|
RDOG
ALPS REIT Dividend Dogs ETF
|
$35.75 | -- | -- | -- | $0.56 | 6.59% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.048 | -- | -- |
|
ACES
ALPS Clean Energy ETF
|
-- | 1.018 | -- | -- |
|
AMLP
Alerian MLP ETF
|
-- | 0.912 | -- | -- |
|
ENFR
ALPS Alerian Energy Infrastructure ETF
|
-- | 0.781 | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 0.796 | -- | -- |
|
RDOG
ALPS REIT Dividend Dogs ETF
|
-- | 0.918 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
|
ACES
ALPS Clean Energy ETF
|
-- | -- | -- | -- | -- | -- |
|
AMLP
Alerian MLP ETF
|
-- | -- | -- | -- | -- | -- |
|
ENFR
ALPS Alerian Energy Infrastructure ETF
|
-- | -- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
RDOG
ALPS REIT Dividend Dogs ETF
|
-- | -- | -- | -- | -- | -- |
ALPS Medical Breakthroughs ETF vs. Competitors
-
Which has Higher Returns SBIO or ACES?
ALPS Clean Energy ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat ALPS Clean Energy ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SBIOALPS Medical Breakthroughs ETF-- -- -- ACESALPS Clean Energy ETF-- -- -- -
What do Analysts Say About SBIO or ACES?
ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Clean Energy ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than ALPS Clean Energy ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than ALPS Clean Energy ETF.
Company Buy Ratings Hold Ratings Sell Ratings SBIOALPS Medical Breakthroughs ETF0 0 0 ACESALPS Clean Energy ETF0 0 0 -
Is SBIO or ACES More Risky?
ALPS Medical Breakthroughs ETF has a beta of 0.772, which suggesting that the stock is 22.758% less volatile than S&P 500. In comparison ALPS Clean Energy ETF has a beta of 1.555, suggesting its more volatile than the S&P 500 by 55.475%.
-
Which is a Better Dividend Stock SBIO or ACES?
ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 3.87%. ALPS Clean Energy ETF offers a yield of 0.93% to investors and pays a quarterly dividend of $0.02 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. ALPS Clean Energy ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SBIO or ACES?
ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than ALPS Clean Energy ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than ALPS Clean Energy ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while ALPS Clean Energy ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for ALPS Clean Energy ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SBIOALPS Medical Breakthroughs ETF-- -- -- -- ACESALPS Clean Energy ETF-- -- -- --
-
Which has Higher Returns SBIO or AMLP?
Alerian MLP ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat Alerian MLP ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SBIOALPS Medical Breakthroughs ETF-- -- -- AMLPAlerian MLP ETF-- -- -- -
What do Analysts Say About SBIO or AMLP?
ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Alerian MLP ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than Alerian MLP ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than Alerian MLP ETF.
Company Buy Ratings Hold Ratings Sell Ratings SBIOALPS Medical Breakthroughs ETF0 0 0 AMLPAlerian MLP ETF0 0 0 -
Is SBIO or AMLP More Risky?
ALPS Medical Breakthroughs ETF has a beta of 0.772, which suggesting that the stock is 22.758% less volatile than S&P 500. In comparison Alerian MLP ETF has a beta of 0.739, suggesting its less volatile than the S&P 500 by 26.063%.
-
Which is a Better Dividend Stock SBIO or AMLP?
ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 3.87%. Alerian MLP ETF offers a yield of 7.85% to investors and pays a quarterly dividend of $0.98 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. Alerian MLP ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SBIO or AMLP?
ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than Alerian MLP ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than Alerian MLP ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while Alerian MLP ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for Alerian MLP ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SBIOALPS Medical Breakthroughs ETF-- -- -- -- AMLPAlerian MLP ETF-- -- -- --
-
Which has Higher Returns SBIO or ENFR?
ALPS Alerian Energy Infrastructure ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat ALPS Alerian Energy Infrastructure ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SBIOALPS Medical Breakthroughs ETF-- -- -- ENFRALPS Alerian Energy Infrastructure ETF-- -- -- -
What do Analysts Say About SBIO or ENFR?
ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Alerian Energy Infrastructure ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than ALPS Alerian Energy Infrastructure ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than ALPS Alerian Energy Infrastructure ETF.
Company Buy Ratings Hold Ratings Sell Ratings SBIOALPS Medical Breakthroughs ETF0 0 0 ENFRALPS Alerian Energy Infrastructure ETF0 0 0 -
Is SBIO or ENFR More Risky?
ALPS Medical Breakthroughs ETF has a beta of 0.772, which suggesting that the stock is 22.758% less volatile than S&P 500. In comparison ALPS Alerian Energy Infrastructure ETF has a beta of 0.852, suggesting its less volatile than the S&P 500 by 14.785%.
-
Which is a Better Dividend Stock SBIO or ENFR?
ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 3.87%. ALPS Alerian Energy Infrastructure ETF offers a yield of 4.43% to investors and pays a quarterly dividend of $0.38 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. ALPS Alerian Energy Infrastructure ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SBIO or ENFR?
ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than ALPS Alerian Energy Infrastructure ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than ALPS Alerian Energy Infrastructure ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while ALPS Alerian Energy Infrastructure ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for ALPS Alerian Energy Infrastructure ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SBIOALPS Medical Breakthroughs ETF-- -- -- -- ENFRALPS Alerian Energy Infrastructure ETF-- -- -- --
-
Which has Higher Returns SBIO or PTH?
Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SBIOALPS Medical Breakthroughs ETF-- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -
What do Analysts Say About SBIO or PTH?
ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings SBIOALPS Medical Breakthroughs ETF0 0 0 PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 -
Is SBIO or PTH More Risky?
ALPS Medical Breakthroughs ETF has a beta of 0.772, which suggesting that the stock is 22.758% less volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.839, suggesting its less volatile than the S&P 500 by 16.123%.
-
Which is a Better Dividend Stock SBIO or PTH?
ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 3.87%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.03 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SBIO or PTH?
ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SBIOALPS Medical Breakthroughs ETF-- -- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- --
-
Which has Higher Returns SBIO or RDOG?
ALPS REIT Dividend Dogs ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat ALPS REIT Dividend Dogs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SBIOALPS Medical Breakthroughs ETF-- -- -- RDOGALPS REIT Dividend Dogs ETF-- -- -- -
What do Analysts Say About SBIO or RDOG?
ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS REIT Dividend Dogs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than ALPS REIT Dividend Dogs ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than ALPS REIT Dividend Dogs ETF.
Company Buy Ratings Hold Ratings Sell Ratings SBIOALPS Medical Breakthroughs ETF0 0 0 RDOGALPS REIT Dividend Dogs ETF0 0 0 -
Is SBIO or RDOG More Risky?
ALPS Medical Breakthroughs ETF has a beta of 0.772, which suggesting that the stock is 22.758% less volatile than S&P 500. In comparison ALPS REIT Dividend Dogs ETF has a beta of 1.152, suggesting its more volatile than the S&P 500 by 15.195%.
-
Which is a Better Dividend Stock SBIO or RDOG?
ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 3.87%. ALPS REIT Dividend Dogs ETF offers a yield of 6.59% to investors and pays a quarterly dividend of $0.56 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. ALPS REIT Dividend Dogs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SBIO or RDOG?
ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than ALPS REIT Dividend Dogs ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than ALPS REIT Dividend Dogs ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while ALPS REIT Dividend Dogs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for ALPS REIT Dividend Dogs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SBIOALPS Medical Breakthroughs ETF-- -- -- -- RDOGALPS REIT Dividend Dogs ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Apple Stock Not Joining the Broader Market Rally?
The S&P 500 has sprinted 4.92% higher so far in…
Will Google Stock Double by 2030?
If you bought Alphabet (NASDAQ: GOOGL) when Gmail launched in…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 54x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
NKE alert for Jun 30
Nike [NKE] is down 2.3% over the past day.
Buy
81
KTOS alert for Jun 30
Kratos Defense & Security Solutions [KTOS] is up 0.7% over the past day.
Sell
44
GDXU alert for Jun 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 2.57% over the past day.
